The projected growth rates are of 7% for 2009, 7% for 2010, 8% for 2011 and 9% for 2012 (Hoovers). Wyeth is expected to increase at higher rates due to its being taken over by Pfizer. 3. Stock Price Analysis The Wyeth stock is being currently (Sep Continue Reading...
(Drug Creation Process: Learn and Confirm, a new Paradigm for Clinical Development at Wyeth) Pharmaceuticals - a knowledge driven industry: Pharmaceuticals happen to be one of the most extremely 'Knowledge Driven' industries that is always in a st Continue Reading...
Wyeth may have been prescient in recognizing the need to break the mold in pharmaceutical research: the old model of heavy, expensive and long research projects (with a concomitant high rate of failure) needed to be addressed. Also, the earlier emph Continue Reading...
Direct to Consumer Advertising HISTORY OF DRUG ADVERTISING THE DTC ADVERTISING PHENOMENON CREATING DEMAND DECEPTIVE ADVERTISING - A WOLF IN SHEEP'S CLOTHING CAUSE OF DEATH PROFIT UTILIZATION, PRICING, AND DEMOGRAPHICS LEGISLATION, POLITICS AN Continue Reading...
Pharmaceutical industries have to operate in an environment that is highly competitive and subject to a wide variety of internal and external constraints. In recent times, there has been an increasing trend to reduce the cost of operation while compe Continue Reading...
caregivers of individuals with AD Caregivers of Individuals with Alzheimer's Disease Alzheimer's disease is a terribly debilitating disease that strikes older adults and for which there is no known cure. According to the Institute on Aging, Alzheim Continue Reading...
